Schedule 13D ownership disclosure
Tokai Pharmaceuticals Inc
Security class unavailable · CUSIP: 88907J107
Event date: 2016-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 39.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-002838
- Form type
- SC 13D
- Filer
- Otic Pharma, Ltd.
- CIK
- CIK 1693786
- Filed
- Jan 05, 2017
- Reporting period
- Dec 21, 2016
- Description
- Schedule 13D beneficial ownership